Scinai Immunotherapeutics Ltd (2F50) News

MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy

FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment MAIA Biotechnology, Inc., (NYSE...

Form 8-K - Current report

MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent

New science for cancer therapy drives powerful value proposition Exceptional measures of efficacy by lead drug THIO in Phase 2 clinical trial...

Form 8-K - Current report

MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer

THIO’s favorable disease control and overall response rates exceed reported standard-of-care data in third line treatment MAIA Biotechnology...

Form 8-K - Current report

Form 8-K - Current report

MAIA Biotechnology to Present at the BIO International Convention 2024

MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, announced its...

MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Poster to present new efficacy data from Phase 2 THIO-101 trial in non-small cell lung cancer (NSCLC) MAIA Biotechnology, Inc., (NYSE American:...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

Original seed investor has remained top MAIA stockholder MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a...

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement

Dr. Smith has participated in every MAIA funding round MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage...